Connect with us

Technology

Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board

Published

2 years ago

on

Dr Hoekema brings over four decades of successful biotech and life science leadershipDr Cora Griffin appointed to head up business development, follows recent appointment of Simon Jones as CFO/COONew hires to accelerate ambition to turbocharge the discovery platform, develop innovative therapeutic pipeline and expand pharma relationships

SOUTHAMPTON, England, Oct. 2, 2024 /PRNewswire/ — Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the further strengthening of its leadership team with the appointments of Andre Hoekema as Chair of the Board and Cora Griffin as Head of Business Development. The appointments continue the strong momentum at Curve following the recent appointment of Simon Jones as CFO/COO.

Dr Hoekema is a highly experienced and successful biotech executive with 40 years’ experience in the industry. He served as Chief Business Officer and member of the Executive Committee at Galapagos Pharma for 18 years, with responsibility spanning M&A, business development and IP. During his time at Galapagos, he led multiple pharma partnerships, acquisitions and divestments, including two landmark deals with Gilead. He was also part of the team that completed successful IPOs on Euronext (2005) and Nasdaq (2015). Andre serves as a member of the supervisory advisory boards of Artax Biopharma, Fibrocor Therapeutics and Mimetas BV.

Curve has also appointed Cora Griffin, an accomplished life sciences business development professional and entrepreneur, as Head of Business Development. Dr Griffin has considerable experience in developing and implementing portfolio strategies from start-ups to large pharmaceutical companies. She was previously Head of Business Development & Alliance Management at ReViral and was instrumental in the acquisition by Pfizer for US$525 million. Cora served as Anti-infectives Strategy Lead at Pfizer, responsible for the Infectious Diseases portfolio strategy for the Research Unit. She is a Jury Member for the EIC Accelerator program for the European Innovation Council and Board Observer at Oppilotech.

Simon Kerry, Chief Executive Officer of Curve Therapeutics, said: “Following the significant Series A financing, we are building a world-class leadership team to turbocharge our proprietary discovery platform and rapidly progress our pipeline. Andre’s wealth of experience in the sector and significant track record, and Cora’s visionary outlook and strategic nous, will be invaluable as we grow the business and progress our lead candidate towards the clinic. We are well placed to accelerate our ambition to build out the pipeline and work with strategic partners to address complex and challenging disease targets and improve patient outcomes.”

Andre Hoekema, PhD, new Chair of Curve Therapeutics, commented: “Curve is an ambitious and innovative biotech with the mission to revolutionize the drug discovery space with its Microcycle discovery platform. Through its pioneering and truly unique approach, Curve is building an innovative therapeutic pipeline and establishing strong relationships with major pharma. I look forward to working with Simon and the leadership team to help the Company progress to the next stage of growth.”

About Curve Therapeutics 

Curve Therapeutics is a private biotechnology company pioneering a revolutionary intracellular screening platform to enable the discovery of innovative therapeutics that address complex and challenging disease targets with the potential to transform the lives of patients. Curve originated from world-leading Microcycle research conducted by Professor Tavassoli’s group in the Department of Chemistry at the University of Southampton, UK. Curve is backed by blue chip investors including Advent Life Sciences, Epidarex Capital, Pfizer Ventures, Columbus Venture Partners and British Patient Capital. Curve has a US$1.7bn global research collaboration with MSD the trade name of Merck & Co., Inc., Kenilworth, NJ USA, to discover and validate modulators of up to five therapeutic targets using its Microcycle technology, initially for oncology and neurology indications. For more information visit: www.curvetx.com.

About Curve’s Microcycle platform

Curve has developed an IP-protected, mammalian cell platform technology, for functional screening and enrichment of diverse hexameric cyclic peptide Microcycle libraries, to identify those library members that have the desired biological activity against a therapeutic target. Curve’s platform allows direct screening for biologically active library members inside mammalian cells and facilitates small molecule hit-to-lead programs. A key advantage of the technology is that both the library and the target are present in all their native conformations within a cell. Uniquely, the compact size and rigid structure of Microcycles enables the design of non-peptide small molecule leads. The disease agnostic discovery platform can be used for a wide range of therapeutically relevant targets, including protein-protein and protein-DNA interactions, and has been used by Curve to develop a pipeline of cancer programs against targets including a dual HIF-1/HIF-2 inhibitor and an inhibitor of ATIC homodimerization.

View original content:https://www.prnewswire.co.uk/news-releases/curve-therapeutics-further-strengthens-leadership-team-with-the-appointment-of-andre-hoekema-as-new-chair-of-board-302264539.html

Related Topics:
Continue Reading

Technology

Kontron Launches Two New KBox F-Series Industrial Computers To Bring Greater Flexibility and Scalability to Industrial Edge Computing

Published

14 minutes ago

on

October 21, 2026

By

TAIPEI, Oct. 21, 2026 /PRNewswire/ — Kontron, a leading global provider of IoT/Embedded Computing Technology (ECT), expands its KBox F-Series with the KBox F-203-RPS and KBox F-204-RPS, two compact industrial computers designed to address diverse requirements in intelligent Industry 4.0, edge computing and industrial IoT applications.

Both systems are powered by 12th, 13th or 14th Gen Intel® Core™ i9/i7/i5/i3 S-Series socket-type processors with a TDP of up to 65 W and support up to 96 GB DDR5 memory, providing a scalable computing foundation for demanding industrial applications requiring flexible performance configuration and long-term deployment.

The KBox F-203-RPS offers two LAN configurations with either two or four GbE ports, allowing customers to select the connectivity level that best fits their applications. The dual-LAN configuration provides an efficient solution for general industrial computing, equipment control and edge applications, while the four-LAN configuration offers additional network connectivity for applications involving multiple devices or network segments, such as machine vision, industrial automation and IoT gateways.

For applications requiring greater system expandability, the KBox F-204-RPS provides one PCIe x16 or two PCIe x8 expansion slots, offering the flexibility to integrate graphics, networking, AI acceleration or other add-on cards according to specific application requirements. With support for up to four 2.5-inch SATA HDDs/SSDs, it also provides extensive storage scalability for data-intensive workloads. These capabilities make the KBox F-204-RPS particularly suitable for industrial edge computing, machine vision, video processing and applications requiring additional functionality or large local data storage.

Together, the KBox F-203-RPS and KBox F-204-RPS enable customers to select the configuration that best matches their requirements, from a slimmer, network-focused industrial computer to a highly expandable edge computing platform.

To learn more about KBox F-203-RPS and KBox F-204-RPS, refer to https://www.kontron.com/en/products/kbox-f-203-rps/p301099 and https://www.kontron.com/en/products/kbox-f-204-rps/p311867.

About Kontron

At Kontron, we champion IoT and Industry 4.0, by creating secure, state-of-the-art solutions that span hardware, software and services. Our approach speeds market entry, reduces the cost of ownership, and offers longevity, ensuring our role as your trusted partner in the integration of smart technologies. For more information, please visit www.kontron.com, dial +886-2-2799-2789 or email SalesAsia@kontron.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/kontron-launches-two-new-kbox-f-series-industrial-computers-to-bring-greater-flexibility-and-scalability-to-industrial-edge-computing-302909761.html

SOURCE Kontron

Continue Reading

Technology

Mouser Electronics Brings Smart Sensing Solutions to PSECE 2026

Published

14 minutes ago

on

October 21, 2026

By

MANILA, Philippines, Oct. 21, 2026 /PRNewswire/ — Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, announces its participation in the 21st Philippine Semiconductor and Electronics Convention and Exhibition (PSECE 2026) from October 26 to 28 at the SMX Convention Center Manila, Philippines. This event underscores Mouser’s commitment to supporting the region’s growing electronics design community with immediate access to cutting-edge technologies.

Visitors are invited to meet the Mouser team at Booth #110-111 to explore new products and practical design resources. The booth features a live demonstration of Würth Elektronik’s smart sensing and visual indication solutions, integrating environmental and motion sensing with programmable visual feedback and wireless connectivity. This interactive display illustrates how modern devices can detect physical conditions and translate them into clear, immediate visual data, addressing the critical need for reliable intelligence in connected systems.

“As we advance into an era of interconnected intelligence, Mouser remains committed to bridging the gap between cutting-edge components and real-world application,” said Daphne Tien, Vice President of Marketing and Business Development at Mouser APAC. “Our presence at PSECE 2026 underscores our dedication to empowering engineers with the tools they need to innovate. We look forward to fostering a vibrant ecosystem where technology translates into tangible progress for the Philippines and beyond.”

Mouser’s participation highlights its strategic objective to strengthen ties with local partners and accelerate the adoption of advanced semiconductor technologies. By providing a platform for knowledge exchange, the company aims to help design communities turn promising prototypes into practical applications.

Attendees will have the opportunity to gather invaluable insights, learn industry best practices, and connect with professionals from across the region. The booth also features interactive activities where visitors can win premium gadgets and engineering tools, making innovative technology more approachable for everyone.

To learn more about Mouser’s presence at PSECE 2026, visit https://www.mouser.ph/psece-seipi/. 

For more Mouser news and our latest new product introductions, visit https://www.mouser.com/newsroom/.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/mouser-electronics-brings-smart-sensing-solutions-to-psece-2026-302914806.html

SOURCE Mouser Electronics

Continue Reading

Technology

Workato Launches Self-Serve Platform in Singapore, Opening Enterprise AI to a Broader Community of Builders

Published

14 minutes ago

on

October 21, 2026

By

New offering gives developers, students, and customers access to the full power of Workato’s enterprise-grade engine to build AI agents and MCP servers

SINGAPORE, Oct. 21, 2026 /PRNewswire/ — Workato®, the leading Control and Execution Platform for Enterprise AI, today announced the launch of a new self-service offering that gives customers, developers, and students across Asia access to the Workato platform to govern and scale their AI initiatives, including building and productionizing AI agents and MCP servers.

Making AI accessible has been at the heart of Workato’s mission the past several years. Through the AI Institute Alliance, unveiled in September 2025, Workato partnered with leading institutes of higher learning across Singapore, including Nanyang Polytechnic, Republic Polytechnic, Temasek Polytechnic, Singapore Polytechnic, Ngee Ann Polytechnic, the Singapore University of Social Sciences, and the National University of Singapore. The initiative equipped students and educators with automation and AI skills.

The AI Lab, which opened a year later, extended that commitment further into the public sector through its partnership with EDB, and into inclusive hiring through SG Enable.

The newly launched self-serve platform will provide users access to:

A free account to start building immediately, with the option to upgrade to a paid plan, no contract required, as projects growThe ability to build recipes, Agents/Genies, and MCP servers directly on the platformThe same governed, enterprise-grade engine that powers Workato’s largest deploymentsA path built for independent developers, students, and small teams, as well as large enterprises

Since launching in 2026 in North America, Workato has seen rapid growth in the builder community. The platform is enterprise grade, but free to get started. As builders solve problems for their business, they can grow by upgrading to a paid plan. With this launch in Singapore, Workato is making an investment in the local builder community.

“The next era of AI won’t be defined by who has access to intelligence, but by who can turn it into action. We’re putting the same enterprise-grade power trusted by the world’s largest companies into the hands of every builder. We want everyone to be able to transform how their business operates,” said Rishi Mallik, Chief Growth Officer, Workato. 

Workato showcased its self-serve platform and broader community initiatives at World of Workato (WOW) 2026 in Singapore.

Builders can sign up now at https://app.trial.workato.com/users/sign_up_trial?utm_content=sg_wow2026.

About Workato

Workato is the leading Control and Execution Platform for Enterprise AI — the neutral platform enterprises trust to put AI to work across their business. Workato unifies data, applications, and processes into a single platform so AI can reliably orchestrate business processes in production at enterprise scale. Built on more than a decade of running mission-critical processes for over half the Fortune 500 — including Nasdaq, Cisco, Vodafone, Atlassian, and Lucid Motors — Workato turns over 17,000 enterprise systems AI needs to act on into one governed execution layer. For more information, visit workato.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/workato-launches-self-serve-platform-in-singapore-opening-enterprise-ai-to-a-broader-community-of-builders-302914795.html

SOURCE Workato

Continue Reading

Trending